While current supplies of these novel medications are limited due to production bottlenecks (Lipanovic, 2024), one might expect a decrease in patient out-of-pocket costs due to expansion of production capacity (Novo Nordisk, 2024), increased market competition (Liu et al., 2021, Collins et al., 2024), expanded insurance coverage (Liu and Rome, 2024, Cubanski and Neuman, 2024), and, eventually, expiration of patent protections (Alhiary et al., 2023)
Then there's biotin, often called the "beauty vitamin" for good reason
Telehealth keeps follow-ups convenient once youre established, while in-person visits handle labs and the conversations that are easier face to face
Systemic redox biomarkers and their relationship to prognostic risk markers in autosomal dominant polycystic kidney disease and IgA nephropathy
Some see incredible results within the first few weeks of their tirzepatide protocol
As an antioxidant, it helps neutralize harmful free radicals that can contribute to the development of heart disease
